YTE reported $2.62B in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 645.73M 28.25M
Agenus AGEN:US $ 92.85M 42.81M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
Biogen BIIB:US $ 7183.7M 464.2M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Bluebird Bio BLUE:US $ 903.53M 194.01M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Cerulean Pharma CERU:US $ 14.06M 4.46M
Chemocentryx CCXI:US $ 317.13M 73.51M
Clovis Oncology CLVS:US $ 296.35M 43.84M
Cti Biopharma CTIC:US $ 74.82M 35.47M
Eli Lilly And LLY:US $ 17295.5M 691M
Exelixis EXEL:US $ 1593.25M 158.98M
Gilead Sciences GILD:US $ 14498M 1220M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Idera Pharmaceuticals IDRA:US $ 43.48M 3.54M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
IONIS PHARMACEUT IONS:US $ 2238.42M 249M
Macrogenics MGNX:US $ 367M 7.72M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Moderna Inc MRNA:US 10.97B 734M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Neurocrine Biosciences NBIX:US $ 1110.1M 24.7M
Newlink Genetics NLNK:US 113.48M 6.12M
Novartis NOVN:VX 23.81B 1.61B
Novartis NVS:US $ 23808M 1610M
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Puma Biotechnology PBYI:US $ 167.75M 3.99M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
Ultragenyx Pharmaceutical RARE:US $ 949.49M 121.44M
Vertex Pharmaceuticals VRTX:US $ 8457.51M 81.79M
YTE INCY:US $ 2620.06M 170.09M